Diaphragm pacing and noninvasive respiratory management of amyotrophic lateral sclerosis/motor neuron disease

Abstract

CNIV prolonged the survival of 113 of the 354 non-DP and 6 DP ALS/MND patients by 12.8 and 10.2 months, respectively. DP provided no benefit on VC or mechanical ventilation-free survival.